Donatus Ekwueme, PhD
CDC health economists like Dr. Donatus Ekwueme estimate the burden of disease and the effectiveness of prevention measures. The need for health economists at CDC has grown in tandem with the cost of health care. As costs have grown, so has the interest in prevention, and economic analyses that can help justify prevention programs.
In the Division of Cancer Prevention and Control's Epidemiology and Applied Research Branch, Dr. Ekwueme studies the economic ramifications of cancer screening programs. Much of his attention now is focused on estimating the economics of the National Breast and Cervical Cancer Early Detection Program, a federally funded cancer screening program that provides support and assistance to uninsured and underserved low-income women 18–64 years for cervical screening, and 40–64 years for breast screening and diagnostic services.
The most recent articles Dr. Ekwueme has first-authored include—
- 2014 Impact of the National Breast and Cervical Cancer Early Detection Program on cervical cancer mortality among uninsured low-income women in the U.S., 1991—2007.
- 2014 Medical costs and productivity losses of cancer survivorsUnited States, 20082011.
- 2014 Analysis of the benefits and costs of a national campaign to promote colorectal cancer screening: CDC's Screen for Life National Colorectal Cancer Action Campaign.
- 2013 Health and economic impact of breast cancer mortality in young women, 1970–2008.
- 2013 An exploratory analysis of the benefits and costs of a national campaign to promote colorectal cancer screening: CDC's Screen for Life: National Colorectal Cancer Action Campaign.
- 2011 The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity—United States, 2000 to 2006.
- 2008 Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
- 2008 Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
- 2008 Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis—United States, 2003.
- 2007 Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies.
- 2002 Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa.
- Centers for Disease Control and Prevention
Division of Cancer Prevention and Control
c/o CDC Warehouse
3719 N Peachtree Rd
Building 100 MS F-76
Chamblee GA 30341
TTY: (888) 232-6348
- Contact CDC-INFO